" class="no-js "lang="en-US"> Heather Moses - Medtech Alert
Monday, November 11, 2024
Heather Moses

Heather Moses

About Heather Moses

Related Story

Novartis Receives GB Licence for Scemblix®▼ (Asciminib), the First STAMP Inhibitor for Patients With Chronic Myeloid Leukaemia

June 17 2022

Novartis UK has announced that Scemblix® (asciminib) has been granted Marketing Authorisation in Great Britain by […]